Konstantinos Tsioris
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.8MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2023 | NSF | SBIR Phase II SBIR Phase II:A high throughput microfluidic platform to accelerate biomanufacturing transitions in biologics development | $1.2M | ONECYTE BIOTECHNOLOGIES, INC. |
| Sep 14, 2023 | NSF | SBIR Phase II SBIR Phase II: A high throughput microfluidic platform to accelerate biomanufacturing transitions in biologics development | $1.7M | ONECYTE BIOTECHNOLOGIES, INC. |
| Sep 2, 2020 | NSF | SBIR Phase I SBIR Phase I: A high throughput microfluidic platform to accelerate biomanufacturing transitions in the COVID-19 response | $256K | ONECYTE BIOTECHNOLOGIES, INC. |
| Sep 1, 2020 | NSF | SBIR Phase I SBIR Phase I: A high throughput microfluidic platform to accelerate biomanufacturing transitions in the COVID-19 response | $256K | ONECYTE BIOTECHNOLOGIES, INC. |
| Jul 1, 2018 | NSF | SBIR Phase I SBIR Phase I: A High Throughput Microfluidics Platform to Measure Secretion from Single Cells | $225K | ONECYTE BIOTECHNOLOGIES, INC. |
| Jun 14, 2018 | NSF | SBIR Phase I SBIR Phase I: A High Throughput Microfluidics Platform to Measure Secretion from Single Cells | $225K | ONECYTE BIOTECHNOLOGIES, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#423
Awards as PI#315
Patents#273
Companies
- ONECYTE BIOTECHNOLOGIES, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.